Intellipharmaceutics International Inc. (IPCI)

[doogdilinger]

Intellipharmaceutics to Present at the 28th Annual ROTH Conference



TORONTO, March 8, 2016 (GLOBE NEWSWIRE) -- Intellipharmaceutics International Inc. (Nasdaq:IPCI) (TSX:I) ("Intellipharmaceutics" or the "Company"), a pharmaceutical company specializing in the research, development and manufacture of novel and generic controlled-release and targeted-release oral solid dosage drugs, today announced that the Company is scheduled to present at the 28th Annual ROTH Conference on March 15, 2016. The presentation will take place at 2:00 P.M. (PT) at the Ritz Carlton Laguna Niguel, Orange County California.



The presentation may be accessed through the Investor Relations' Events and Presentations section on Intellipharmaceutics' website at www.intellipharmaceutics.com.